The goal of this observational study is to evaluaty the accuracy of current risk stratification of patients with endometrial cancer and to redefine lymph node staging recommendations based on real-world clinical data. The main question it aims to answer is: Is there any group of patients who doesn't need lymph node staging for proper indication of adjuvant treatment? Participants are note taking any intervention. They are treated according to current standard of care and followed 3-years after primary surgery.
Study Type
OBSERVATIONAL
Enrollment
350
No intervention
The accuracy of preoperative risk stratification
Time frame: From enrollment to the first follow-up visit at 4 weeks after surgery.
Determination of specific groups for whom: 1) lymph node staging is crucial for changing risk category and adjuvant treatment decisions, and 2) lymph node staging could be safely omitted
Time frame: From enrollment to the first follow-up visit at 4 weeks after surgery.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.